Within the span of three years, Rajesh Sharma, an entrepreneur hailing from India and the owner of Advanced LifeScience, has undertaken the ambitious endeavor of constructing a pharmaceutical plant in the Special economic zone of technical-innovative type “Dubna”. The decision to build the plant was made last year, and today the expert council for industrial and production has approved the company’s business plan for this project.
The area of the plant will be about 10,000 square meters, which will also include a drug development center and a warehouse for finished products. As it stated, proximately 1.1 billion rubles will be invested in the construction and launch of the plant.
Production of drugs, including pharmaceutical substances and finished products for the treatment of lung, breast, thyroid cancer, and various other types of cancer, is scheduled to commence in the second quarter of 2026.
